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ABSTRACT
Introduction: Angiogenesis plays an important role in the growth and metastasis of colorectal
carcinoma, which is currently one of the targets of cancer therapy. It has been reported that the
Endoglin (CD105) involved in angiogenesis and is a powerful marker for angiogenesis in colorectal
carcinoma. Level Quantitative angiogenesis in peritumor and an intratumor area is important to
know because it is closely related to the micro-environmental factors that influence the occurrence
of cancer angiogenesis. The goal of this study to analyze the distribution pattern of angiogenesis in
colorectal cancer by comparing the distribution of angiogenesis in peritumor and intratumor areas
between well, moderate and poorly differentiated colorectal carcinoma, and between metastasis
and non-metastatic colorectal cancer. Methods: This study analyzed fifty samples of resected
adenocarcinoma colorectal. Angiogenesis was assessed by the immunohistochemical method using
a primary monoclonal antibody Endoglin (CD105). Positive expression of CD105 was assessed
through the CD105 protein expression in neovascular endothelial cells, while the distribution pat-
tern of angiogenesis assessed by counting the positive expression of CD105 protein in hot spots by
using the MVD (microvessel density) in the peritumor and intratumor areas and then performed
statistical analysis. Results: There is a significant difference between the quantitative level of an-
giogenesis in peritumor and intratumor areas of well (P<0.01), moderate (P<0.01) and poorly (<0.05)
differentiated adenocarcinoma. The significant difference between the quantitative levels of angio-
genesis in peritumor and intratumor areas of non-metastatic colorectal cancer (P<0.01) and lymph
node metastases (<0.05) was found, but not in colorectal cancer with liver metastasis. Conclu-
sion: Angiogenesis pattern is more concentrated in peritumor compared to intratumor areas. This
showed the role of stromal cells in-angiogenesis. There is significant expression between angio-
genesis in peritumor and intratumor areas.
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INTRODUCTION
Colorectal carcinoma is a malignancy
derived from the large intestine that caused
by uncontrolled cell growth.1 Colorectal can-
cer is the third most common cancer in men
(746.000 cases, 10.0% of the total)  and sec-
ond in women (614.000 cases, 9.2% of total)
worldwide. Almost 55% of the cases occur in
more developed regions. Mortality is 694.000
death (8.5% of the total) with more deaths
(52%) in developed regions of the world.,2
In the 1980s researchers proposed a
four-step progression of gene alterations in
colonic epithelium. This phenomenon starts
from transformation of normal epithelium to
an adenoma, proceeding to in situ carcinoma,
and ultimately to an invasive and metastatic
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tumor. In 1990, Fearon and Vogelstein eluci-
dated specific pathways essential to the de-
velopment of CRC, consisting of accumulated
mutations in multiple genes that regulate cell
growth and differentiation.2 Both genetic and
epigenetic alterations, the latter leading to
aberrant methylation of tumor suppressor
genes, result in inactivation of these genes
and subsequent promotion of neoplasia.3
The main causes of death in colorectal
carcinoma is due to metastasis. Metastasis is
the process by which tumors spread from the
primary organ and appear in other organs.
There are four mechanisms of metastasis in
colorectal carcinoma is through direct inva-
sion, transperitonial, hematogen, and lymphonia.
Many factors can occur initiated a process of
metastasis, among others; damage to cells
adhesion molecule, release of angiogenic
growth factors, release lymphangiogenic of
growth factors, mechanical factors, release of
proteolytic enzymes and motility of cancer
cells.4,5
It was reported, tumor growth and me-
tastasis depend on tumor angiogenesis,
where tumor would not grow over 1-2 mm in
diameter without angiogenesis. Angiogenesis
is a formation of a new blood vessel in
peritumor and intratumor from established
blood vessel through sprouting mechanism.
Neovascularization due to angiogenesis allow
tumor growth and metastasis by providing
nutrition and oxygen for tumor cell, and also
a medium for budding from the main tumor
through blood vessel to metastasize to another
organ.6,7
Due to induction of angiogenesis in solid
tumors is related to tumor progression, an-
giogenesis becomes an important target for
the detection, diagnosis, and treatment of
cancer. Currently, angiogenesis emerged as
targets of cancer therapy that has been used
in the treatment of cancer, including colorectal
cancer and until now still being investigated.8-10
CD105 (Endoglin) was reported as a
marker of endothelial cell in neovascularization.
CD105 (Endoglin), a cell adhesion molecules,
was expressed in cell surface located in 9q34,
an 180 kDa homodimeric transmembrane gly-
coprotein, a component of TGF-beta (Trans-
forming Growth Factor-Beta) receptor com-
plex, a pleiotropic cytokine which modulated
angiogenesis through cell regulation includ-
ing proliferation, differentiation, and migration.
CD105 bind TGF-beta 1 and 3 then modulate
TGF-beta signal through interaction with TGF
receptor 1 and/or II.11
CD105 exclusively expressed in colorectal
carcinoma angiogenesis and few other organ
carcinomas through its positive expression in
endothelia cell in de novo blood vessels, ei-
ther in the intratumor or peritumor area. In
contrast, CD105 almost not expressed in en-
dothelia cell in normal tissue capillary around
the tumor. Furthermore, CD105 expression in
endothelia cell is very selective without any
significant cross-reactivity with cell inflamma-
tory, stroma cell in neoplasm tissue, even in a
lymph vessel endothelial cell.13 Many reports,
neovascular count through MVD (microvessel
density) method with CD105 marker is better
estimator for prognosis and tumor survival
compared to MVD method using panendothelial
marker, such as CD31.12,13
It has been reported that CD105 is in-
volved in the formation of angiogenesis and seem
to be a powerful marker for neovascularization in
colorectal carcinoma. At present, CD105
emerged as a major vascular target for anti-
angiogenic cancer therapy.12,14 However, how
it was expressed and level of angiogenesis in
peritumor and the intratumor area is impor-
tant due it is closely related to known environ-
mental factors that affect the occurrence of
tumor angiogenesis. To our knowledge, has
not been reported the distribution patterns of
angiogenesis in intratumor and peritumor ar-
eas of colorectal carcinoma and its relation to
histopathologic finding,  The purposes of this
research is to evaluate the distribution pat-
tern of angiogenesis in peritumor and
intratumor of colorectal carcinoma and its re-
lation to the histopathologic finding.
METHODS
Tumor sample
Fifty (50) surgical resection of colorectal
carcinoma derived from Hospital in Makassar
during 2007-2008. All specimens/samples
were fixed in formalin and paraffin blocks then
stained with HE (hematoxylin-eosin) to diag-
nose colorectal carcinoma. All samples are
adenocarcinoma subtype based on histopa-
thology sample stratified by Japanise classifi-
cation for colorectal cancer, comprising; 13
well-differentiated, 37 moderate differentiated,
10 poorly differentiated.
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Surgical resection of colorectal carci-
noma tissue obtained from Pathology
Anatomy Department. The tissues were cut
in the central region of cancerous tissue and
1-2 cm surrounding non-cancerous tissue in
the oral and anal margin. Tissue have been
cut then made to paraffin blocks and cooled
in the refrigerator and cut with a microtome
with a thickness of 3 microns. Object glass
smeared with albumin to glued the tissue.
Then, cut tissue put in a water bath (<60°C).
Tissue in a water bath then taken with an al-
bumin smeared glass object, slide then
drained then placed on the slide warmer
(<60°C) for 15 minutes. The slide then ready
for staining. Slide contain paraffin block tis-
sue soaked in xylol for 5 minutes, performed
2 times in 2 different containers, then soaked
in 95% alcohol for 2 minutes, also done 2
times in 2 different containers. After that,
soaked in 70% alcohol for 2 minutes, rinsed
with running water for 5 minutes. Then,
soaked for 15 minutes with Hematoxylin
Mayer, rinsed with running water until turned
blue. After that, soaked slide with eosin 1%
for 5 minutes, 70% alcohol for 2-5 minutes,
95% alcohol for 2-5 minutes, performed 2
times in 2 different containers, soaked with
Carbol Xylol for 5 minutes, soaked with xylol
for 2-5 minutes. After that, the slide dried, then
cover with glass deck. The slide is ready to
be viewed under a microscope.
Immunohistochemisry staining is done
with an indirect immuno-enzyme technique
using labeled streptavidin complex. Before
staining process begins slide are differenti-
ated with xylene for 15 minutes dan rehydrated
with 100% alcohol and alcohol concentration
is diluted to 90%, 80%, 70% and 60% for 10
minutes each. After that, the slides are washed
with dH20 2 times for 5 minutes and incubated
with PBS solution for 5 minutes. Then, slides
are put into glass box containing EDTH (pH8)
and heated in the microwave for 6 minutes
for optimized its antigenicity. The slide is
cooled at room temperature for 1 hour, and
after briefly dried, the slide is marked using a
pap pen. Slides washed with dH20 and PBS
solution for 5 minutes each before incubation
with 0.3% hydrogen peroxidase for 15 min-
utes. After endogenous peroxidase blocked,
the slides were incubated with blocking solu-
tion for 30 minutes to block avidin in the tis-
sue. Then, the slides were incubated overnight
at -40C temperature with primary CD105 an-
tibody (Santa Cruz) diluted to 1:50. Slides are
washed again 3 times with dH20 before incu-
bated with secondary antibody (goat anti-
mouse) and streptavidin during each 30 min-
utes at room temperature. For staining, 3.3
diaminobenzidine tetrahydrochloride used for
approximately 10 minutes to obtain the stain-
ing reaction that can be detected by micro-
scopic examination. After that stained again
with hematoxylin to clarify the cell nucleus for
30 seconds and washed with running water
for 5 minutes, the slide is dehydrated by us-
ing the alcohol concentration increased gradu-
ally from 70%, 80%, 90% to 100% for 2 min-
utes each. After that, slides soaked into xy-
lene for 5 minutes. Last, slides were given
malinol before it covered with the glass cover.
The CD105 level of immunoexpression
was assessed by using the method of
intratumoral and peritumoral MVD
(microvessel density). With low magnification
(×40), each peritumor and intratumor area
selected five most populated microvessel/
neovascular areas (hotspots) expressing the
positive CD105 marker. In each area, with high
magnification (×100), microvessel count is
conducted in microvessel/neovascular CD105
positive expression. Each microvessel where
one or more of endothelial cells stained posi-
tive (brown) by immunohistochemical CD105
marker, is counted as one microvessel/
neovascular. Blood vessels with lumen-look-
ing, defined as non-neovascular, it was not
calculated. The intensity of CD105 expression
grouped as: 0 (negative): none or <20% of
endothelial cells with an expression of weak
positive CD105; 1+ (weak):> 20% of endot-
helial cells with expression of weak positive
CD105; 2+ (strong):> 20% of endothelial cells
with expression of strong positive CD105.
Characterization of angiogenesis distribution
pattern in peritumor and the intratumor area
is designated after the conclusion of
microvessel counts. Immuno-histochemical
evaluation will be carried out individually by
the researcher (RM and UM) to get accurate
results
Data were statistically analyzed using
Spearman ‘p’ correlation and multivariate
analysis. The quantity difference in microvessel
count is compared using paired ‘t’ test. All sta-
tistical tests were performed using SPSS 17.0,
windows. The statistical is significant if p
<0.05.
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RESULTS
Fifty (50) surgical resection of colorectal
carcinoma derived from Hospital in Makassar
during 2007-2008. All specimens/samples
were fixed in formalin and paraffin blocks then
stained with HE (hematoxylin-eosin) to diag-
nose colorectal carcinoma. All samples are
adenocarcinoma subtype based on histopa-
thology sample stratified by Japanise classifi-
cation for colorectal cancer, comprising; 13
well-differentiated, 37 moderate differentiated,
10 poorly differentiated. Thus, the clinical pa-
thology data samples are in the table 1.
Based on tumor metastasis, patients with
tumors without lymph node metastasis are 13
subjects ( 8 men and 5 women), with an aver-
age age of 58+2. Metastasis to lymphonodus
was found in 29 subjects (24 men and 5
women) with a mean age of 63+6, and me-
tastasis to the liver was found in 8 subjects (6
men and 2 women) with an average age of
63+8. Well, differentiation Colorectal cancer
was found in 7 subjects, metastasis to lymph
nodes was found in 1 subject, and metastasis
to the liver was found in 2 subjects. Colorectal
cancer with moderate differentiation without
metastasis are found in subjects, metastasis
to lymph node are found 27 subjects and
metastasis to the liver are found in 4 subjects.
No poorly differentiated colorectal cancer with-
out metastasis was found, metastasis to lymph
nodes in 1 subject and metastasis to the liver
2 subjects (Tabel.2).
No.
Number of patients 50
Age (yrs)
Range (median) 39-78 (62)
Gender
Male 38
Female 12
Adenocarcinoma 50
Histopathology diagram
Well differentiated 10
Moderately differentiated 37
Poorly differentiated 3
Metastasis to lymph nodes                                     28
Metastasis to other organ                                          88
Table 1. Clinical pathology and histopathology of
samples
LN meta(+) LN meta(-) Hepar meta(+)
n=29 n=13 n=8
Gender 24 M / 5 F 8 M / 5 F 6 M / 2 F
Age
Range (years) 40-71 39-68 56-69
Mean (years) 63+6 58+2 63+8
Grade
Well differentiated (n=10) 1 7 2
Moderatelly differentiated (n=37) 27 6 4
Poorly differentiated (n=3) 1 0 2
Patient 
LN meta; Limfonodus metastasis, M; male, F; female, WD; well differentiated, MD;moderatelly differentiated, PD;
poorly differentiated
Table 2. Distribution of samples based on metastasis
Expression of CD105 (Endoglin)
Fifty samples were used, all of the
samples (100%) showed positive expression
of CD105 on neovascular endothelial cells in
peritumor; 46 (92%) strong expression and
only 4 (8%) weak expression. There is 31
(62%) of the total sample show positive ex-
pression of CD105 on neovascular endothe-
lial cells in the intratumor area; 17 (34%)
strong expression, and 14 (28%) weak expres-
sion. (Table. 2)
There is a significant difference of CD105
expression on neovascular endothelial cell in
peritumor and intratumor areas based on the
grading histopathology of adenocarcinoma
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Location n
Positive 
expression of 
CD105 (%)
Peritumor 50 50 (100)
Strong 46 (92)  
Weak 4 (8)  
Intratumor 50 31 (62)
Strong 17 (34)
Weak 14 (28)
Table 3. Distribution of CD105 positive expression on
neovascularization in peritumor and intratumor area of
colorectal carcinoma
colorectal, wherein well-differentiated adeno-
carcinoma there is 674 positive expression of
CD105 on neovascular endothelial cells in
peritumor and 297 in the intratumor area with
p<0.01. In moderate differentiated, 1028 ex-
pressed positive CD105 in peritumor and 589
on intratumor with p <.001. In poorly differen-
tiated adenocarcinoma, there are 128 ex-
pressed positive CD105 in peritumor and 84
in intratumor with p <.005. (Table.4)
In non-metastatic adenocarcinoma, there
is 689 positive expression of CD105 on
neovascular endothelial cells in peritumor and
104 in intratumor. In lymph nodes, metastatic
colorectal cancer shows 1423 positive expres-
sion of CD105 on neovascular endothelial
cells in peritumor and 583 in intratumor. We
found  798 positive expressions of CD105 on
neovascular endothelial cells in peritumor and
207 in the intratumor area of liver metastatic
colorectal cancer.
Peritumor Intratumor p
Grade
W ell differentiated (n=10) 674 297 <0.01
M oderatelly differentiated (n=37) 1028 589 <0.01
Poorly dif ferentiated (n=3) 128 84 <0.05
LN non-meta (n=8) 689 104 <0.01
LN meta (n=29) 1423 583 <0.05
Liver meta (n=13) 798 207 0.07
Protein CD105 Expression 
LN meta; Lymph node metastasis, M; male, F; female, WD; well differentiated, MD;moderately differentiated, PD;
poorly differentiated
Tabel 4. The levels of protein expression of CD105 on peritumor and intratumor area based on  histopathology grading
dan correlation between the level of expression of CD105 protein with histopathological grading in colorectal carcinoma
We found a significant difference be-
tween level expression of CD105 on neo-vas-
cular endothelial cell in peritumor and
intratumor areas, either in non metastasis and
lymphoid metastatic adenocarcinoma colorectal
with a p-value of p<0.01 and p> 0.05, respec-
tively, but no significant differences of CD105
expression between peritumor and intratumor
area in liver metastatic adenocarcinoma was
found (p=0.07). (Table.4)
DISCUSSION
By using CD105 as an exclusive marker
to angiogenesis, this study proves that there
are significant differences in protein expres-
sion of CD105 on peritumor and intratumor
area nor in well, moderately and poorly differ-
entiated tumor with p-value p<001 for well and
moderately differentiated, and p<005 for
poorly differentiated. It was suspected due to
the difference in environmental factor sur-
rounding the tumor effect the number nor rate
of angiogenesis in peritumor and intratumor
are, both in well, moderately, and poorly dif-
ferentiated tumor. This study also found in-
creased number of neovascularization ex-
pressed positive CD105 in well differentiated
to moderately differentiated, both in peritumor
and intratumor with p-value <0.01, respec-
tively.
Angigenesis is controlled by the balance
between proangiogenetic and inhibitor factor.
Disturbance of the balance caused the dis-
turbance on angiogenesis process. The in-
volvement of a cascade complex begins with
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activation of vascular endothelial with
proangiogenetic factor nor cytokine, followed
by proliferation and invasion of angiogenesis
with the involvement of extracellular remod-
eling matrix. Next step is maturation and sta-
bilization.15
This study also proved the significant dif-
ference between angiogenesis level in
peritumor and intratumor areas, both on non-
metastases and lymph node metastatic ad-
enocarcinoma colorectal, p<0.01 dan p<0.05,
respectively. In liver metastatic adenocarci-
noma colorectal, there is no significant differ-
ence of CD105 expression on neovascular
endothelial cell in peritumor and intratumor
(p=0.07), it was suspected due to a low num-
ber of samples (n=3). This study also found
an increased number of neovascularization
which marked with positive expression of
CD105 in non-metastatic and lymph nodes
metastatic adenocarcinoma colorectal in
CONCLUSION
Based on this study, we conclude that
Angiogenesis pattern is more concentrated in
peritumor compared to intratumor areas. This
showed the role of stromal cells in angiogen-
esis. There is significant expression between
angiogenesis in peritumor and intratumor ar-
eas. The results of this study provide a fun-
damental data for a strategy of antiangiogenic
cancer therapy.
peritumor and intratumor areas, p<0.01 dan
p<0.05, respectively (Table.4)
Angiogenesis was reported as an impor-
tant process for tumor growth, invasion, and
metastasis. Previously, angiogenesis has
been reported occur on peritumor and
intratumor areas in the certain type of tumor,
including colorectal carcinoma.16
Weitz J, Koch M, Debus J, et al. Colorectal
cancer. Lancet. 2005; 365 (9454):153-165.
WHO. Colorectal cancer: Estimated incidence,
mortality and prevalence worldwide in 2012.
Globocan 2012. Available: http://globocan.
iarc.fr/Pages/fact_sheets_cancer. aspx?
cancer=colorectal
Fearon ER, Vogelstein BA. genetic model for
colorectal tumorigenesis. Cell. 1990; 61(5):
759–767.
Symptom of colorectal cancer. colorectal can-
cer association of canada 2011. Available at:
http//:www.colorectal-cancer.ca/en/just-the-
facts/symptoms/.
August DA, Ottow RT, Sugarbaker PH. Clini-
cal perspective of human colorectal cancer
metastasis. Cancer Metastasis Rev. 1984;
3(4):303-324.
Folkman J. Tumor angiogenesis: therapeutic
implication. N Engl J Med. 1971; 285: 1182-
1186.
Folkman J. What is the evidence that tumor
are angiogenesis dependent?. J Natl Cancer
Inst. 1990; 82: 4-6
GrotheyA, Allegra C. Antiangiogenesis therapy
the treatment  of  metastatic colorectal cancer.
Ther Adv Med Oncol. 2012; 4(6): 301-319.
Arjaans M, Schröder CP, de Vries EG, et al.
VEGF pathway targeting agents, vessel nor-
malization and tumor drug uptake: from bench
to bedside. Oncotarget. 2016; 7(16): 21247-
21258.
REFERENCES
1.
2.
3.
4.
5.
6.
7.
8.
9.
Sandra FM, Rui MR, Antonio MR, et al. Role
of endoglin and VEGF family expression in
colorectal cancer prognosis and anti-angio-
genic therapies. World J Clin Oncol. 2011; 10;
2(6): 272-280.
Nassiri F, Cusimano MD, Lloyd RV, et al.
Endoglin (CD105): a review of its role in
angiogenesis and tumor  diagnosis,  progres-
sion  and therapy. Anticancer Res. 2011; 31(6):
2283-2290.
Minhajat R, Daisuke M, Tokunaga O, et al.
Endoglin (CD105) expression in angiogenesis
of colon cancer: analysis using tissue
microarrays and comparison with other endot-
helial markers. Virchows Arch. 2006; 448(2):
127-34
Minhajat R, Daisuke M, Tokunaga O, et al.
Organ-specific endoglin (CD105) expression
in the angiogenesis of human cancers. Pathol
Int. 2006; 56(12): 717-23.
Rosen LS, Gordon MS, Matei DE, et all.
Endoglin for targeted cancer treatment. Curr
Oncol Rep. 2014; 16(2): 365.
Tonini T, Rossi F, Claudio PP. Oncogene. 2003;
29; 22(42): 6549-9556.
Shieh YS, Lee HS, Shiah SG, at al. Role of
angiogenic and non angiogenic mechanisms
in oral squamous cell carcinoma: correlation
with histologic differentiation and tumor pro-
gression. J Oral Pathol Med. 2004; 33(10):
601-6.
10.
11.
12.
13.
14.
15.
16.
Minhajat et al /  Distribution Patterns of Angiogenesis
